5.07 USD
0 (0%)
5.29 USD
+0.22 (+4.34%)
We assign a fundamental rating of 2 out of 10 to XYLO. XYLO was compared to 186 industry peers in the Health Care Equipment & Supplies industry. XYLO may be in some trouble as it scores bad on both profitability and health. XYLO has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year XYLO has reported negative net income.
- XYLO had a negative operating cash flow in the past year.
1.2 Ratios
- XYLO's Return On Assets of -16.05% is in line compared to the rest of the industry. XYLO outperforms 54.45% of its industry peers.
- Looking at the Return On Equity, with a value of -33.51%, XYLO is in line with its industry, outperforming 54.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.05% | ||
| ROE | -33.51% | ||
| ROIC | N/A |
ROA(3y)-17.06%
ROA(5y)N/A
ROE(3y)-42.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- XYLO has a worse Gross Margin (22.38%) than 78.01% of its industry peers.
- In the last couple of years the Gross Margin of XYLO has declined.
- The Profit Margin and Operating Margin are not available for XYLO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.38% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.16%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- XYLO does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, XYLO has more shares outstanding
- XYLO has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -3.16, we must say that XYLO is in the distress zone and has some risk of bankruptcy.
- XYLO has a worse Altman-Z score (-3.16) than 64.40% of its industry peers.
- XYLO has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
- XYLO's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. XYLO outperforms 63.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.16 |
ROIC/WACCN/A
WACC8.8%
2.3 Liquidity
- XYLO has a Current Ratio of 1.14. This is a normal value and indicates that XYLO is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.14, XYLO is not doing good in the industry: 84.82% of the companies in the same industry are doing better.
- XYLO has a Quick Ratio of 1.14. This is a normal value and indicates that XYLO is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.14, XYLO is not doing good in the industry: 70.16% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 66.37% over the past year.
- Looking at the last year, XYLO shows a very negative growth in Revenue. The Revenue has decreased by -67.45% in the last year.
- Measured over the past years, XYLO shows a very strong growth in Revenue. The Revenue has been growing by 43.44% on average per year.
EPS 1Y (TTM)66.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.26%
Revenue 1Y (TTM)-67.45%
Revenue growth 3Y43.44%
Revenue growth 5YN/A
Sales Q2Q%-72.47%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y1216.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for XYLO. In the last year negative earnings were reported.
- XYLO is valuated cheaply with a Price/Forward Earnings ratio of 0.79.
- Based on the Price/Forward Earnings ratio, XYLO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.26, XYLO is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.79 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- XYLO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- XYLO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
XYLO TECHNOLOGIES LTD / XYLO FAQ
What is the fundamental rating for XYLO stock?
ChartMill assigns a fundamental rating of 2 / 10 to XYLO.
What is the valuation status of XYLO TECHNOLOGIES LTD (XYLO) stock?
ChartMill assigns a valuation rating of 4 / 10 to XYLO TECHNOLOGIES LTD (XYLO). This can be considered as Fairly Valued.
Can you provide the profitability details for XYLO TECHNOLOGIES LTD?
XYLO TECHNOLOGIES LTD (XYLO) has a profitability rating of 1 / 10.
What is the expected EPS growth for XYLO TECHNOLOGIES LTD (XYLO) stock?
The Earnings per Share (EPS) of XYLO TECHNOLOGIES LTD (XYLO) is expected to grow by 1216.67% in the next year.
How sustainable is the dividend of XYLO TECHNOLOGIES LTD (XYLO) stock?
The dividend rating of XYLO TECHNOLOGIES LTD (XYLO) is 0 / 10 and the dividend payout ratio is 0%.